Ahjay, the way you see it makes totally sense and is according...

Ahjay, the way you see it makes totally sense and is according to textbook. But what we currently observe in the US is everyone is grabbing anything that has immunology written on just to say "Hey, look, we did not miss the boat". Yesterday's article here reported a 300m t/o despite a failed PH 2 as just the IP and data were valued that high. What I and maybe many missed is that IMU got its hands on a huge data base /IP from Ohio / Mayo, a fact not considered here at all. Plus the success so far with HerVaxx should see IMU at a very low risk buy when it comes to grab what's available.

Often big comps forget the basics when in a rush or too greedy, best example BHP with its US shale gas purchase and the stuffed up t/o attempt of RIO.

I would like to see IMU partner with the big guys or becoming a VAX developer / seller to create billions of $ in royalties and to make sure the development / research continues to benefit the whole world not just some white collar guys.

But that would be too good to be true, a multi billion $ company working for the people, or could it become reality?

GLTA